Two consecutive phase II trials of biweekly oxaliplatin plus weekly 48-hour continuous infusion of nonmodulated high-dose 5-fluorouracil as first-line treatment for advanced colorectal cancer

1. Abad, A.
2. Carrato, A.
3. Navarro, M.
4. Sastre, J.
5. Cervantes, A.
6. Antón, A.
7. Martinez-Villacampa, M.
8. Marcuelllo, E.
9. Massutí, B.
10. Aranda, E.
11. Manzano, J.L.
12. Guallar, J.L.
13. Diaz-Rubio, E.